期刊文献+

信息预警在规避药品风险中的应用 被引量:3

The Application of Early-warning System in Avoiding Drug Risk
下载PDF
导出
摘要 为有效控制医院药品风险,提出信息预警的风险管理模式。信息预警系统利用信息采集、信息分析评估、信息报告等对药品风险进行预警,详细说明了该预警体系的建立、运作机制、模式及关键技术环节。 By suggesting an early-warning system to make effective control of drug risk. By the use of information collecting system, information analyzing system and information reporting system to avoid drug risk.It also describes in detail the establishment, operation mechanism and the key technical points of the early-warning system.
作者 陈崇泽
出处 《中国药物警戒》 2009年第7期389-392,共4页 Chinese Journal of Pharmacovigilance
关键词 信息预警 药品风险 药品不良反应 early warning system drug risk adverse drug reaction(ADR)
  • 相关文献

参考文献6

  • 1Leus E,Walckiers D.Early Warning System on Drugs at Public Health Level in Belgium[EB/OL].2002-05[2008-06-18].http://www.iph.fgov.be/epidemio/epien/birn/EWS02.pdf.
  • 2Kinner S A,Degenhardt L.Reflections on the development and implementation of an early warning system for ecstasy and related drug markets in Australia[J].Drug Alcohol Rev,2006,25(5):445-449.
  • 3Griffiths P,Vingoe L,Hunt N,et al.Drug information systems,early warning,and new drug trends:can drug monitoring systems become more sensitive to emerging trends in drug consumption[J].Subst UseMisuse,2000,35(6-8):811-844.
  • 4Grenier-Sennelier C,Lombard I,Jeny-Loeper C.Designing adverse event prevention programs using quality management methods:the case of falls in hospital[J].Int J Qual Health Care,2002,14(5):419-426.
  • 5郭晓昕,武志昂,张承绪.全面认识美国FDA的药品风险管理体系[J].中国药物警戒,2007,4(1):1-5. 被引量:14
  • 6陈崇泽.医院药品风险管理初探[J].中国药物警戒,2008,5(2):101-103. 被引量:5

二级参考文献8

  • 1陈易新.如何通过上市后药品安全性监测实现药品风险管理[J].中国药师,2007,10(4):375-377. 被引量:33
  • 2[1]Janice K B,Wanju S D,Gretchen S D,et al.The Art and Science of Risk Management[J].Drug Safety,2006,28(1):1-18.
  • 3[2]Guideline for industry:EIA.The extent of population exposure to assess clinical safety for drugs intended for long-term treatment of non-life-threatening conditions[EB/OL].[2006-11-23].http://www.fda.gov/cdr/guidance/ichela.pdf.
  • 4[3]Enclosure pdufa reauthorization performance goals and procedures[EB/OL].[2006-11-23].Http://www.fda.gov/oc/pdufa/PDUFAIII Goals.Html.
  • 5[2]Wu L T,Howard M O.Is inhalant use a risk factor for heroin and injection drug usc among adolescents in the United States?[J].Addictive Behaviors,2007,32(2):265-281.
  • 6[3]Saul A.Models of Phase 1 vaccine trials:optimization of trial design to minimize risks of mumpIe serious adverse events[J].Vaccine,2005,32(2):3068-3075.
  • 7[4]Triller D M,Clause S L,Hamilton B A.Risk of adverse drug events by patient destination after hospital discharge[J].Am J Health-Syst Pharm,2005,62(18):1883-1889.
  • 8[5]Newman B Y.Drug interactions:Reducing the risk[J].Optometry-Journal of the American Optomeaic Association,2007,78(8):385-386.

共引文献16

同被引文献20

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部